Table 3 |
|||||||
|
CRP haplotype frequency, mean baseline CRP, DAS28, and change in DAS28 |
|||||||
|
H1 |
G |
C |
T |
0.31 |
34.01 (28.28, 40.91) |
6.37 (6.20, 6.54) |
-1.95 (-1.69, -2.21) |
|
H2 |
A |
C |
C |
0.27 |
29.91 (24.34, 36.78) |
6.28 (6.09, 6.46) |
-1.81 (-1.51, -2.01) |
|
H3 |
G |
C |
C |
0.31 |
31.87 (26.63, 38.14) |
6.37 (6.20, 6.53) |
-2.13 (-1.87, -2.38) |
|
H4 |
G |
C |
A |
0.05 |
30.32 (18.04, 50.96) |
6.73 (6.26, 7.20) |
-2.32 (-1.59, -3.06) |
|
H5 |
A |
G |
C |
0.06 |
21.97 (13.46, 35.86) |
6.33 (5.89, 6.78) |
-2.46 (-1.76, -0.15) |
|
|
|||||||
|
CI, confidence interval; CRP, C-reactive protein; DAS28, 28-joint-count disease-activity score. |
|||||||
|
Plant et al. Arthritis Research & Therapy 2012 14:R214 doi:10.1186/ar4052 |
|||||||